We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-14.52%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$26.7M
AUM Growth
-$4.54M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$24.4M 91.35%
3,773,530
CMPS
2
Compass Pathways
CMPS
$2.04B
$2.31M 8.65%
278,880

Similar funds

Founders Fund VII Management's Q2 2023 Portfolio in Review

As of Q2 2023, Founders Fund VII Management held 2 positions worth $26.7M, down 15% from $31.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Founders Fund VII Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's ten largest holdings make up 100% of its $26.7M portfolio in Q2 2023.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q2 2023.
  • Founders Fund VII Management's portfolio value fell 15% quarter-over-quarter to $26.7M.

Based on Founders Fund VII Management's 13F filing for Q2 2023, filed 14 Aug 2023.